BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
DTSTART:20240310T030000
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:CDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20231105T010000
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:CST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP;TZID=America/Chicago:20260410T131037
UID:192167@calendar.wisc.edu
DTSTART;TZID=America/Chicago:20240126T120000
DTEND;TZID=America/Chicago:20240126T130000
DESCRIPTION:Keaven M. Anderson\, PhD\, Scientific AVP\, Methodology Researc
 h\, Merck &amp\; Co.\, Inc.. Phase 3 clinical trials support whether to ap
 prove an experimental treatment for clinical use and marketing. These clin
 ical trials answer a number of questions. Some can be answered early in th
 e trial (reduction in tumor size\, for example) and others take longer\, s
 uch as improvement in overall survival. Dr. Anderson will discuss a number
  of approaches that could offer gains in efficiency for interim analyses o
 f clinical trials.\n\nCONTACT: junjie.hu@wisc.edu\n\nURL: https://biostat.
 wiscweb.wisc.edu/events/department-seminars/\n\nONLINE: https://uwmadison.
 zoom.us/j/95515534304
LOCATION:1360 Genetics-Biotechnology Center Building  (Also offered online)
SUMMARY:BMI Seminar: Weighted Parametric Multiple Tesst Procedures in Group
  Sequential Design (WPGSD)
URL;VALUE=URI:https://biostat.wiscweb.wisc.edu/events/department-seminars/
END:VEVENT
END:VCALENDAR